Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
41.36
+1.79 (4.52%)
At close: Jul 30, 2026, 4:00 PM EDT
41.48
+0.12 (0.29%)
After-hours: Jul 30, 2026, 7:51 PM EDT
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $7.07 billion as of July 30, 2026. Its market cap has increased by 328.02% in one year.
Market Cap
7.07B
Enterprise Value
6.44B
1-Year Change
328.02%
Ranking
Category
Stock Price
$41.36
ChartMarket Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $7.07B, an increase of 5,588.31%. That is a compound annual growth rate of 94.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 7.07B | 30.82% |
| Dec 31, 2025 | 5.40B | 527.16% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxcyte | 7.84B |
| TG Therapeutics | 7.61B |
| ImmunityBio | 7.58B |
| Rhythm Pharmaceuticals | 7.26B |
| Mirum Pharmaceuticals | 6.75B |
| Erasca | 6.35B |
| Belite Bio | 6.22B |
| CG Oncology | 6.19B |